ACN 📈 Accenture - Overview
Exchange: NYSE • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00B4BNMY34
ACN: Strategy, Consulting, Technology, Operations, Data, Analytics, Automation
Accenture plc is a multinational professional services company that offers a wide range of services, including strategy and consulting, industry X, song, and technology and operation services, to clients across various regions, including North America, Europe, the Middle East, Africa, and internationally. The company's service portfolio encompasses systems integration and application management, security, intelligent platform, infrastructure, software engineering, data and AI, and automation services, enabling businesses to streamline their operations, enhance efficiency, and drive growth.
Accenture's capabilities extend to operating business processes, designing, manufacturing, and assembling automation equipment, robotics, and other commercial hardware products, which cater to diverse industries such as communications, media, and technology; banking and capital markets, and insurance; health and public service; consumer goods, retail, travel services; industrial; life science; chemicals, natural resources, energy, and utilities sectors. By leveraging its expertise and resources, the company helps clients navigate complex challenges, capitalize on emerging opportunities, and achieve their strategic objectives.
The company has established a collaboration agreement with Kyoto University to advance learning, research, and innovation in human-centered AI, underscoring its commitment to staying at the forefront of technological advancements and fostering a culture of innovation. With a history dating back to 1951, Accenture is headquartered in Dublin, Ireland, and has evolved into a leading provider of IT consulting and other services, with a strong online presence at https://www.accenture.com. The company's common stock is traded under the ISIN code IE00B4BNMY34, and it is classified under the GICS Sub Industry: IT Consulting & Other Services.
Additional Sources for ACN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ACN Stock Overview
Market Cap in USD | 224,123m |
Sector | Technology |
Industry | Information Technology Services |
GiC Sub-Industry | IT Consulting & Other Services |
IPO / Inception | 2001-07-19 |
ACN Stock Ratings
Growth 5y | 51.4% |
Fundamental | 68.8% |
Dividend | 65.4% |
Rel. Strength Industry | -61.5 |
Analysts | 4/5 |
Fair Price Momentum | 360.06 USD |
Fair Price DCF | 355.71 USD |
ACN Dividends
Dividend Yield 12m | 1.46% |
Yield on Cost 5y | 2.73% |
Annual Growth 5y | 15.52% |
Payout Consistency | 98.8% |
ACN Growth Ratios
Growth Correlation 3m | 12.5% |
Growth Correlation 12m | 5.4% |
Growth Correlation 5y | 73% |
CAGR 5y | 13.31% |
CAGR/Mean DD 5y | 0.87 |
Sharpe Ratio 12m | 0.14 |
Alpha | -21.41 |
Beta | 1.02 |
Volatility | 26.93% |
Current Volume | 7013.2k |
Average Volume 20d | 2634.7k |
As of December 21, 2024, the stock is trading at USD 366.37 with a total of 7,013,200 shares traded.
Over the past week, the price has changed by +2.14%, over one month by +2.60%, over three months by +9.41% and over the past year by +9.65%.
Yes, based on ValueRay Fundamental Analyses, Accenture (NYSE:ACN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 68.81 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACN as of December 2024 is 360.06. This means that ACN is currently overvalued and has a potential downside of -1.72%.
Accenture has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy ACN.
- Strong Buy: 12
- Buy: 6
- Hold: 7
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, ACN Accenture will be worth about 400.5 in December 2025. The stock is currently trading at 366.37. This means that the stock has a potential upside of +9.32%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 385.1 | 5.1% |
Analysts Target Price | 335.8 | -8.3% |
ValueRay Target Price | 400.5 | 9.3% |